Cargando…
Predictors of All-Cause Mortality Among People With Human Immunodeficiency Virus (HIV) in a Prospective Cohort Study in East Africa and Nigeria( )
BACKGROUND: Introduction of antiretroviral therapy (ART) has been associated with a decline in human immunodeficiency virus (HIV)-related mortality, although HIV remains a leading cause of death in sub-Saharan Africa. We describe all-cause mortality and its predictors in people living with HIV (PLWH...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464064/ https://www.ncbi.nlm.nih.gov/pubmed/34864933 http://dx.doi.org/10.1093/cid/ciab995 |
_version_ | 1784787503406907392 |
---|---|
author | Kibuuka, Hannah Musingye, Ezra Mwesigwa, Betty Semwogerere, Michael Iroezindu, Michael Bahemana, Emmanuel Maswai, Jonah Owuoth, John Esber, Allahna Dear, Nicole Crowell, Trevor A Polyak, Christina S Ake, Julie A |
author_facet | Kibuuka, Hannah Musingye, Ezra Mwesigwa, Betty Semwogerere, Michael Iroezindu, Michael Bahemana, Emmanuel Maswai, Jonah Owuoth, John Esber, Allahna Dear, Nicole Crowell, Trevor A Polyak, Christina S Ake, Julie A |
author_sort | Kibuuka, Hannah |
collection | PubMed |
description | BACKGROUND: Introduction of antiretroviral therapy (ART) has been associated with a decline in human immunodeficiency virus (HIV)-related mortality, although HIV remains a leading cause of death in sub-Saharan Africa. We describe all-cause mortality and its predictors in people living with HIV (PLWH) in the African Cohort Study (AFRICOS). METHODS: AFRICOS enrolls participants with or without HIV at 12 sites in Kenya, Uganda, Tanzania, and Nigeria. Evaluations every 6 months include sociobehavioral questionnaires, medical history, physical examination, and laboratory tests. Mortality data are collected from medical records and survivor interviews. Multivariable Cox proportional hazards models were used to calculate adjusted hazard ratios (aHRs) and 95% confidence intervals (CIs) for factors associated with mortality. RESULTS: From 2013 through 2020, 2724 PLWH completed at least 1 follow-up visit or experienced death. Of these 58.4% were females, 25.8% were aged ≥ 50 years, and 98.3% were ART-experienced. We observed 11.42 deaths per 1000 person-years (95% CI: 9.53–13.68) with causes ascertained in 54% of participants. Deaths were caused by malignancy (28.1%), infections (29.7%), and other non-HIV related conditions. Predictors of mortality included CD4 ≤ 350 cells/µL (aHR 2.01 [95% CI: 1.31–3.08]), a log(10)copies/mL increase of viral load (aHR 1.36 [95% CI: 1.22–1.51]), recent fever (aHR 1.85[95% CI: 1.22–2.81]), body mass index < 18.5 kg/m2 (aHR 2.20 [95% CI: 1.44–3.38]), clinical depression (aHR 2.42 [95% CI: 1.40–4.18]), World Health Organization (WHO) stage III (aHR 2.18 [95% CI: 1.31–3.61]), a g/dL increase in hemoglobin (aHR 0.79 [95% CI: .72–.85]), and every year on ART (aHR 0.67 [95% CI: .56–.81]). CONCLUSIONS: The mortality rate was low in this cohort of mostly virally suppressed PLWH. Patterns of deaths and identified predictors suggest multiple targets for interventions to reduce mortality. |
format | Online Article Text |
id | pubmed-9464064 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-94640642022-09-12 Predictors of All-Cause Mortality Among People With Human Immunodeficiency Virus (HIV) in a Prospective Cohort Study in East Africa and Nigeria( ) Kibuuka, Hannah Musingye, Ezra Mwesigwa, Betty Semwogerere, Michael Iroezindu, Michael Bahemana, Emmanuel Maswai, Jonah Owuoth, John Esber, Allahna Dear, Nicole Crowell, Trevor A Polyak, Christina S Ake, Julie A Clin Infect Dis Major Article BACKGROUND: Introduction of antiretroviral therapy (ART) has been associated with a decline in human immunodeficiency virus (HIV)-related mortality, although HIV remains a leading cause of death in sub-Saharan Africa. We describe all-cause mortality and its predictors in people living with HIV (PLWH) in the African Cohort Study (AFRICOS). METHODS: AFRICOS enrolls participants with or without HIV at 12 sites in Kenya, Uganda, Tanzania, and Nigeria. Evaluations every 6 months include sociobehavioral questionnaires, medical history, physical examination, and laboratory tests. Mortality data are collected from medical records and survivor interviews. Multivariable Cox proportional hazards models were used to calculate adjusted hazard ratios (aHRs) and 95% confidence intervals (CIs) for factors associated with mortality. RESULTS: From 2013 through 2020, 2724 PLWH completed at least 1 follow-up visit or experienced death. Of these 58.4% were females, 25.8% were aged ≥ 50 years, and 98.3% were ART-experienced. We observed 11.42 deaths per 1000 person-years (95% CI: 9.53–13.68) with causes ascertained in 54% of participants. Deaths were caused by malignancy (28.1%), infections (29.7%), and other non-HIV related conditions. Predictors of mortality included CD4 ≤ 350 cells/µL (aHR 2.01 [95% CI: 1.31–3.08]), a log(10)copies/mL increase of viral load (aHR 1.36 [95% CI: 1.22–1.51]), recent fever (aHR 1.85[95% CI: 1.22–2.81]), body mass index < 18.5 kg/m2 (aHR 2.20 [95% CI: 1.44–3.38]), clinical depression (aHR 2.42 [95% CI: 1.40–4.18]), World Health Organization (WHO) stage III (aHR 2.18 [95% CI: 1.31–3.61]), a g/dL increase in hemoglobin (aHR 0.79 [95% CI: .72–.85]), and every year on ART (aHR 0.67 [95% CI: .56–.81]). CONCLUSIONS: The mortality rate was low in this cohort of mostly virally suppressed PLWH. Patterns of deaths and identified predictors suggest multiple targets for interventions to reduce mortality. Oxford University Press 2021-12-03 /pmc/articles/PMC9464064/ /pubmed/34864933 http://dx.doi.org/10.1093/cid/ciab995 Text en © The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Major Article Kibuuka, Hannah Musingye, Ezra Mwesigwa, Betty Semwogerere, Michael Iroezindu, Michael Bahemana, Emmanuel Maswai, Jonah Owuoth, John Esber, Allahna Dear, Nicole Crowell, Trevor A Polyak, Christina S Ake, Julie A Predictors of All-Cause Mortality Among People With Human Immunodeficiency Virus (HIV) in a Prospective Cohort Study in East Africa and Nigeria( ) |
title | Predictors of All-Cause Mortality Among People With Human Immunodeficiency Virus (HIV) in a Prospective Cohort Study in East Africa and Nigeria( ) |
title_full | Predictors of All-Cause Mortality Among People With Human Immunodeficiency Virus (HIV) in a Prospective Cohort Study in East Africa and Nigeria( ) |
title_fullStr | Predictors of All-Cause Mortality Among People With Human Immunodeficiency Virus (HIV) in a Prospective Cohort Study in East Africa and Nigeria( ) |
title_full_unstemmed | Predictors of All-Cause Mortality Among People With Human Immunodeficiency Virus (HIV) in a Prospective Cohort Study in East Africa and Nigeria( ) |
title_short | Predictors of All-Cause Mortality Among People With Human Immunodeficiency Virus (HIV) in a Prospective Cohort Study in East Africa and Nigeria( ) |
title_sort | predictors of all-cause mortality among people with human immunodeficiency virus (hiv) in a prospective cohort study in east africa and nigeria( ) |
topic | Major Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464064/ https://www.ncbi.nlm.nih.gov/pubmed/34864933 http://dx.doi.org/10.1093/cid/ciab995 |
work_keys_str_mv | AT kibuukahannah predictorsofallcausemortalityamongpeoplewithhumanimmunodeficiencyvirushivinaprospectivecohortstudyineastafricaandnigeria AT musingyeezra predictorsofallcausemortalityamongpeoplewithhumanimmunodeficiencyvirushivinaprospectivecohortstudyineastafricaandnigeria AT mwesigwabetty predictorsofallcausemortalityamongpeoplewithhumanimmunodeficiencyvirushivinaprospectivecohortstudyineastafricaandnigeria AT semwogereremichael predictorsofallcausemortalityamongpeoplewithhumanimmunodeficiencyvirushivinaprospectivecohortstudyineastafricaandnigeria AT iroezindumichael predictorsofallcausemortalityamongpeoplewithhumanimmunodeficiencyvirushivinaprospectivecohortstudyineastafricaandnigeria AT bahemanaemmanuel predictorsofallcausemortalityamongpeoplewithhumanimmunodeficiencyvirushivinaprospectivecohortstudyineastafricaandnigeria AT maswaijonah predictorsofallcausemortalityamongpeoplewithhumanimmunodeficiencyvirushivinaprospectivecohortstudyineastafricaandnigeria AT owuothjohn predictorsofallcausemortalityamongpeoplewithhumanimmunodeficiencyvirushivinaprospectivecohortstudyineastafricaandnigeria AT esberallahna predictorsofallcausemortalityamongpeoplewithhumanimmunodeficiencyvirushivinaprospectivecohortstudyineastafricaandnigeria AT dearnicole predictorsofallcausemortalityamongpeoplewithhumanimmunodeficiencyvirushivinaprospectivecohortstudyineastafricaandnigeria AT crowelltrevora predictorsofallcausemortalityamongpeoplewithhumanimmunodeficiencyvirushivinaprospectivecohortstudyineastafricaandnigeria AT polyakchristinas predictorsofallcausemortalityamongpeoplewithhumanimmunodeficiencyvirushivinaprospectivecohortstudyineastafricaandnigeria AT akejuliea predictorsofallcausemortalityamongpeoplewithhumanimmunodeficiencyvirushivinaprospectivecohortstudyineastafricaandnigeria AT predictorsofallcausemortalityamongpeoplewithhumanimmunodeficiencyvirushivinaprospectivecohortstudyineastafricaandnigeria |